Collegium Pharmaceutical, Inc. (COLL) Investor Relations Documents

Collegium Pharmaceutical, Inc. (COLL) investor relations documents from the company's IR site: 6 presentations, 34 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

Presentation: Collegium Pharmaceutical (Nasdaq: COLL) August 2026 investor update, projecting $840M in 2026 product sales and $458M in adjusted EBITDA.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-13Press releaseCollegium Announces $50 Million Accelerated Share Repurchase Program
2026-08-06Press releaseCollegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
2026-08-05PresentationPresentation
2026-07-23Press releaseCollegium to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-20Press releaseCollegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
2026-06-05Press releaseCollegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-12Press releaseCollegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
2026-05-07Press releaseCollegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
2026-05-05Earnings deckQ1 2026 Earnings Presentation
2026-04-23Press releaseCollegium to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-08Press releaseCollegium to Participate in Upcoming Investor Conferences
2026-03-19Press releaseCollegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajecto
2026-03-05Press releaseCollegium to Present New Real-World Data at PainConnect 2026
2026-03-03Press releaseParis Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Emp
2026-03-02Press releaseCollegium to Participate in Upcoming Investor Conferences
2026-02-26Earnings deck25-Q4 - Earnings Presentation FINAL.pdf
2026-02-26Press releaseCollegium Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-23Press releaseBoston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
2026-02-12Press releaseCollegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
2026-01-15Press releaseCollegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
2026-01-08Press releaseCollegium Provides 2026 Financial Guidance and Business Update
Press releasePress Release
2025-11-05Earnings deckCOLL Q3 2025 Earnings Presentation FINAL.pdf
Press releaseCollegium to Report Third Quarter 2025 Financial Results on November 6, 2025
Press releasePress Release
2025-08-05Earnings deckCOLL Q2 2025 Earnings Presentation FINAL.pdf
Press releaseCollegium to Report Second Quarter 2025 Financial Results on August 7, 2025
Press releasePress Release
2025-05-07Earnings deckCOLL Q1 2025 Earnings Presentation FINAL.pdf
2025-02-27Press releasePress Release
2024-11-07Press releasePress Release
2024-10-24Press releaseCollegium to Report Third Quarter 2024 Financial Results on November 7, 2024
2024-08-08Press releasePress Release
2024-07-25Press releaseCollegium to Report Second Quarter 2024 Financial Results on August 8, 2024
2024-05-09Press releasePress Release
2024-04-25Press releaseCollegium to Report First Quarter 2024 Financial Results on May 9, 2024
2024-02-22Press releasePress Release
2023-11-07Press releasePress Release
2023-08-03Press releasePress Release
2023-05-04Press releasePress Release

COLL overview · COLL earnings · COLL financials · COLL KPIs · COLL documents · COLL ownership · COLL peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.